1264 participants
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-24
- Start Date:
- 2023-12-21
- Completion:
- 2027-11-30
Conditions
- Carcinoma, Non-Small-Cell Lung
- Neoplasm Metastasis
Interventions
- DRUG
No Results Yet